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ABSTRACT 
BACKGROUND 
Snake bite poisoning is known to man since antiquity. It is a well-known 
occupational hazard amongst farmers, plantation workers, and other outdoor 
workers and results in much morbidity and mortality throughout the world.  
 The acute renal failure in snake bite patients largely a preventable 
complication. So the patients with snake bite should be hospitalized and 
monitored for early detection of renal complications. This study is an attempt 
to analyze the clinical profile of snake bite patients and evaluation of acute 
renal failure in them. 
OBJECTIVES 
To study the renal involvement in patients with snake bite with 
reference to clinical features and the time of onset of acute renal failure. To 
study the course, need for renal replacement therapy including dialysis and 
outcome. 
METHODS 
A prospective clinical study of 100 patients of snake bite from August 
2014 to July 2015 was done to know the clinical profile and outcome in 
Government Vellore Medical College Hospital, Vellore and particularly looked 
for development of acute renal failure. Later each case is studied and 
investigated with respect to clinical features, course in the hospital, onset of 
ARF, need for renal replacement therapy including dialysis and mortality due 
to ARF. Patients were followed till discharge or death. They were treated as per 
protocol. Clinical data was tabulated. Statistical analysis (SPSS) was done. 
RESULTS 
The incidence of ARF was (20%), majority of patients were between 31 
to 50 years of age. Male patients were predominant with (68%) and (32%) were 
female. Most of the patients reported within 4 hours of bite. Common signs and 
symptoms were pain (99%), swelling (81%), cellulitis (26%), hematuria (26%) 
and oliguria (20%). Hypotension was present in (15%) of cases which is an 
important cause of ARF. All the ARF patients showed coagulation 
abnormalities (WBCT >20 minutes). Hemodialysis was done in 5 patients. 
Among 100 patients mortality was (2%) and the remaining (98%) recovered 
completely. 
CONCLUSION 
Causes of ARF in snakebite was multifactorial in origin. Bleeding and 
hypotension are among the important causes of ARF. Type of snakebite is 
another important factor in the development of ARF and Russell's viper bite is 
more commonly associated with ARF. Lapse of time in presenting to the 
hospital and abnormal coagulation profile are the predictors of poor outcome. 
ARF is usually associated with oliguria and generally occurs within 24 hours. 
Most of the ARF patients had recovered completely with effective 
management. 
KEYWORDS: ARF, Oliguria, Coagulation Profile, Viper bite, Lapse of time. 
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INTRODUCTION 
SNAKE BITE POISONING is known to man since antiquity. Bite 
rates are highest in temperate and tropical areas where populations subsist by 
manual agriculture. In INDIA, a large proportion of snake bites occur when 
people are working barefoot in the fields or while walking at night. Recent 
studies estimates somewhere between 1.2 million and 5.5 million snakebites 
worldwide each year, with 421,000-1,841,000 envenomation and 20,000-
94,000 deaths1. 
The principal systemic effects of the envenomation are on the nervous 
system, kidneys, cardio vascular and blood coagulation and locally at the site 
of bite. Renal failure complicates 5.5% to 26.0% of all poisoning from snakes. 
Most cases are due to the Viperidae species of snakes, which includes pit viper, 
Russell’s viper, saw scaled viper, rattlesnake.2 
The complications related to kidneys are observed in majority of 
patients with snake bite admitted in the hospital and is an important cause of 
morbidity and mortality. The onset of renal failure in these patients is signaled 
by the development of oliguria or anuria. This acute renal failure is largely a 
preventable complication. So the patients with snake bite should be 
hospitalized and monitored for early detection of renal complications. Early 
treatment improves survival in snake bite victims. 
This study is an attempt to analyze  the clinical profile of snake bite 
patients and evaluation of outcome in Acute Renal failure in them. 
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OBJECTIVE OF THE STUDY 
 
1. To study the renal involvement in patients with snake bite with 
reference to clinical features and the time onset of renal failure. 
2. To aid in the prompt diagnosis and effective management of acute renal 
failure cases in snake bite. 
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REVIEW OF LITERATURE 
HISTORY 
Snakes have formed an object of awe and curiosity all over the world. 
They have been associated with mysticism apart from being objects of fear.2 
Snake bite may be earliest and most common poison known to human being. 
Myths in the form of stories, dramas and films revolve around dreaded snakes, 
rivalry of snakes, mating of the snakes. Snakes are worshipped in India and the 
auspicious days are marked in the name of snakes.3 
History of snakebites is as old as any civilization and sculptures. The 
earliest scientifically documented reference to Indian snakes available might be 
credited to Dr.Patrick Russell. He differentiated venomous and non-venomous 
snakes especially on viper, Viper Russelli, which is appropriately named after 
him.4,5 Sir J. D. Fayrer (1873) carried out detailed study on the physiology of 
poison of Indian snakes and author a book titled “Thantoophidia of India” in 
the year of 1874. Col. Frank Walls (1908) strived hard to add our knowledge of 
the habits and distribution of snakes in his work entitled “The Poisonous 
Terrestrial Snakes of our British Indian Dominions and How to recognize 
them”. It was Col. Gharpurey (1935), medical man turned ophiologist, who 
first attempted to dispel the ignorance and superstition woven around the 
Indian snakes, both venomous and non-venomous. He wrote book called 
“Snakes of India” in semi technical knowledge. 
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Epidemiology 
Snakes are present all over the earth surface except some islands, Arctic 
and Antarctic. Snakes are poikilotherms and are active around 25-35 degree 
Celsius. These reptiles have  venomous apparatus which consist the fang and 
venom gland. 
Identification of snake type is most important because clinical 
manifestations depends upon species type. Sometimes the fang mark could not 
visible (Krait).  The killed snake brought makes the identification easier.  In 
this case monovalent-ASV may given 
Snake Type 
The important poisonous snakes belong to three major families.    
1. Vipridae family consist two sub families, a. viperianae and crotalinae 
2. Elapidae families have Krait, Cobra, Corel snakes and all Australian 
venoms snakes. 
3. Hydrophidae (Sea Snakes) 
4. Colubridae and Atractaspididae are two other families in which few are 
toxic. 
Global scenario 
Snake bite is a global issue; it is a most common occupational hazard.  
The victims are farmers, plantation workers and others belongs to out-door 
activities in the tropical areas.  The fishermen, swimmers and divers are 
attacked by sea snakes.9  The morbidity and mortality is high in this group.  
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Exotic and poisonous snakes are becoming popular as pets in the western 
world.  In United States 25% of bites occurs during handling of snakes.9 In 
whole world around 3500 species are identifiable.  Among these 350 are 
poisonous.7 
Indian scenario 
In India 216 species are identifiable and 53 are venomous.8  Till now 
there is no reliable statistics are available.  Annually 200,000 snake bites are 
encountered among them 15 – 20000 were died.14 
In west Bengal at Burdhwan district snake bite incident is 0.16%,  and 
mortality rate is 0.016% annually.10  In Maharashtra incident rate is 76 bites 
per 100,000 population with mortality rate of 2.5 per one lakh per annum.11  
Tamilnadu, Maharashtra, Kerala, West Bengal, Uttar Pradesh and Karnataka 
are the states in India with high prevalence rate of snake bites.12 
Age and Sex 
Although snake bite affects all age group, the majority fall between 11-
50 years of age.   Interstate studies in India showed 72% of victims are fall in 
this age group.  The study of Banerjee et al declared that gender distribution 
rate of male and female is 3 : 115.  
Host and environmental factors 
Since most of the incidents are happening in remote areas, the detail of 
statistical analysis of snakebite is difficult and the data availability is 
incomplete.  As an occupational Hazard, it affects herdsmen, farmers, hunters, 
plantation workers and workers on development sites are mostly affected.16 
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Snakebites are more common in summer and in the rainy season, thus show 
seasonal variation7.  Males are affected more than twice than females, and bites 
are more common in lower extremities in negligible envenomation. The reason 
for snakebite is provocation and are inflicted when mistakably trodden.15-18 
Sometimes poisonous snake produce dry bites, that results in negligible 
envenomation varies from 10-80%.19 
Mortality 
The mortality varies 2-11% in various studies.  
Characteristics of Snakes 
Snakes body is elongated and consists of head, tail and body regions. 
The body of snake is covered by scales that are imbricate in primitive snakes 
and form a distinctive covering in other snakes. Special scales are developed 
on the head and characterizes for identifying different snakes. 
 
 
 
 
 
 
 
 
 
Figure 1: Short, permanently erect, fangs of a typical elapid. 
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The snakes don’t have eyelids and the pupils are vertical.  Snakes have 
one pair of internal ears which is primitive and there is no external 
appendage’s. The lower jaw in the snakes has a pair of bones connected 
centrally in front by a firm elastic ligament and it does not articulate with 
maxilla as in mammals. The snakes have a row of teeth on either side of the 
premaxilla and mandible. Venomous type snakes have one pair of fangs on 
premaxilla.  The channel of fangs pours the venom.  In Cobra the channel is 
gutter in nature but in R.viper appears as a hypodermic needle.  The fang ends 
in the venomous gland present on both sides of the jaw underneath the orbit.  
Ventrally this gland extends as a venomous duct which ends in ampulla.    
 
 
 
 
 
 
 
 
 
 
Figure 2a : Monocellate cobra (Naja kaouthia) 
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Figure 2 b: Detail of hood 
 
 
 
 
 
Figure 3: Head of a typical pit viper – white-lipped green pit viper 
(Trimeresurus albolabris) showing the pit organ situated between the 
nostril and the eye. 
 
 
 
 
 
 
 
Figure 4: Russell’s vipers’ details of fangs. 
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Habitat of Snake14 
Snakes are carnivorous reptiles and also belong to poikilothermic; it 
uses venomous apparatus to procure the food.   
It has very close range of limited vision and active on movable object 
with immediate vicinity.  
Approach to Identify Snake Types21 
1. If the tail is laterally compressed, the snake is a sea snake and it is 
poisonous. 
2. If the tail is round, proceed to examine the ventral scales, if the ventral 
scales are narrow or absent, the snake is non-poisonous. If the ventral 
scales are broad, extending across the belly, it may or may not be 
poisonous, to differentiate next examine the head.  
3. If the ventral scales are enlarged and only infra labials are present and 
the last is the largest, it is a krait. 
4. If the head is covered with scales and not with shield the snake is a viper 
and it is poisonous. 
Medically important snakes in India22 
Only six species are responsible for snakebite envenomation in India. 
They belong to family elapid-cobra and kraits; the family viperidae includes 
Russell’s viper and saw scaled viper .The family hydrophidae includes several 
types of sea snakes. 
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Elapids 
Elapids consists of King Cobra, Coral Snake, Common Krait, Cobra and 
Banded Krait  
Cobra :(Najanaja)20 
Cobra seen throughout in India, they are oviparous. It is 1.2 meter 
length and it is black color, but it varies place to place.  The size of the head 
and neck are same.  The pupils round in shape.  The fangs are short, grooved 
and fixed with premaxilla and it lined with mucous membrane. Because of this 
it cannot bite over clothes and delivers less dose.  
 
Fig 5: Showing king cobra 
King Cobra [Raj Naga or NajaBungarus] 
King Cobra habitat in forest and the near vicinities2.  It grows up to 5 
meters length and bigger than normal cobra.  The colour of king cobra is 
Black/ Yellow / Brown or Green, but young one would be jet-black.  You can 
see the white and yellow colour cross bars on the body.  There is no spectacle 
mark on the hood. Tails scales are proximally completed and distally 
separated.  
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Common Krait [Manyar / Bungaruscaerulus] 
This snake grows to a length of 1 to 1.25 meters or even 1.50 meters. 
 
 
 
 
 
 
 
 
Fig 6: Showing common krait 
It is widely seen in India and lives in and around near the residences, 
thus the reason for more number of snakebites20. The colours of the common 
krait is generally glittering black and have single / dual white bows across the 
top in the frequent distance. You can see strip of hexagonal scales present on 
the belly as well as on the back.  The head has large shields and scales in tails 
are complete.    
Viperidae 
 It belongs to ovi-viviparous group.  The head of a viper is triangle, and 
the neck is narrow compared to head with laurel shields and it has elliptical 
pupils. It has long movable canalized fangs, and it look like hypodermic 
needles.  
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It has two different sub families as below  
a. Pit Viper – Rattlesnake  
b. Pit less Viper – Russell’s & Saw Scaled  
Pit vipers [Crotalinae] detect warm-blooded food through the special 
sense organ called pit organ which is resides between the eye and nostril.   
 
Common Green Pit Viper [Hara Phisi/Bamboo Snake/Lachesisgramineus] 
 
 
 
 
 
 
 
Fig 7: Showing common green pit viper 
 
This type of snakes normally lives in the mountains and broadly spread 
across India. You can see this in various sizes ranging from 1 feet to 4 feet.  
Normally it is in bright green colour, infrequently in brown or yellow.   It has 
triangle shape of head, flat broad body with a pit between the nostrils and eye. 
Half white line appears on the flanks, with scales appears on the long tails.   
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Russell’s viper: (Daboia, charn viper, Ghonus or khodchitro) 
 
 
 
 
 
 
 
 
 
Fig 8: Showing Russell’s viper 
It is found all over India except in thick forest. It grows up to 5 – 6 
feet20.  It is in brown / beige colour.  On the top it has 3 strips of almond 
designed spots.  Compared to other poisonous snakes it is stouter and with 
bigger nostrils.  It gives typical hissing noise while about to bite. One can 
easily identified by  
a. Discrete V mark with its apex pointing forward on the flat triangle head 
b. Head has tiny scales. 
c. Extensive whole stomach scales. 
d. Short thin tail with shields spliced in to 2 rows.  
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Saw scaled viper [Echis or Afai/Echiscarinata/Phoorsa] 
You can see this in brown / greenish brown colour and in different sizes 
ranging between 2 and 3 feet. This is also seen across India 
 
 
 
 
 
 
 
 
Fig 9: Showing Sawscaled viper 
Way to identify this snake  
1. Like other vipers it has triangle shape head, with an arrow mark in white 
colour.  
2. Flank has curvy line, with a shape like diamond appeared between the 2 
curvy lines. 
3. Tiny scales in the head.  
4. Wide stomach scales.  
5. Tail shields are not splinted.  
6. Body scales look like saw.  
This produces a odd swishing noise while it moves, due to uneven scales on 
the bottom.  
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Hydrophidae  [Sea snake] 
This can be found in the coastal localities. It has Small head with 
swimming capability through its rubbery flat tail. Even though these snakes are 
poisonous, bites occasionally. Nostrils are there near the nose with valves, and 
they breathe freely through the same. Narrow belly plates with tuberculated 
plates on their bottom. Venom kit is soft and located posteriorly with small 
fixed teeth. 
 
 
 
 
 
 
 
Fig 10: Blue spotted sea snake 
 
 
Snake venom23-25 
In our country 52 [25%] types of snakes are poisonous out of identified 
two hundred types of snakes.   The Common Cobra, Common Krait, R.Viper 
& Saw Scaled Viper are high poisonous.70% of bites are related to Saw-Scaled 
snakes, 25% are related to Russell’s. Insignificant percentage related to Kraits / 
Cobras.  Small snakes bites also to be considered as poisonous snake bite. 
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Physical properties of venom14 
Snake venom is faded see through yellow and is viscous in consistency.  
It is acidic with gravity between 1.03 and 1.07.  It look like crystal once it is 
dried, will melt in water. Exact quantity of venom spit while bite by snake is 
unaware, but deadly dose as below  
S.no Snakes Deadly Dose 
1 Cobra [Common] 120 mg 
2 R.Viper 150 mg 
3 Krait [Common] 60 mg 
4 Saw Scaled Viper  80 mg 
 
Chemical composition 
Venom contains protein (90 To 95 %) and non-protein (5 to10 %) 
compounds. Ninety Percentage of the dry weight is protein.  
 Four broad categories of Toxic component of venom area as below6  
1. Polypeptides 
2. Enzymes 
3. glycoproteins and  
4. Low molecular weight Compounds  
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Pharmacological properties 
Snake venom might have 5 to 15 enzymes, 3 to12 non-enzymatic 
proteins, peptides and minimum six other substances. The snake venoms 
therefore exert a collective action on almost all organ system and on every cell. 
Clinically speaking however, the more important actions are those on the 
cardiovascular system, blood, neural system, kidneys and lungs14. Of the 
various enzymes present in the venom, certain of them have been shown to be 
responsible for some of the significant effects of the poison. Polypeptides 
components of venom is small, so it absorbed rapidly reaches systemic 
circulation, produce toxicity in many vital organs and pre/postsynaptic 
terminals .  
a. Proteinases abundantly present in viper and crotalid venoms, are 
proteolytic enzymes and cause marked tissue destruction17. 
b. Hyaluronidase is present in almost all snake venoms. This component 
aids spread of toxins in tissue planes which helps proteolytic enzymes to 
cause blistering, local oedema, and necrosis.17 
c. Cholinesterases are important enzyme constituents of elapid venom 
and catalyze the hydrolysis of acetyl choline to acetic and choleic acid. 
It has been claimed to have a curare like effect and thus contribute to 
neurotoxicity. 
d. Phospholipase catalyzes the hydrolysis of lipids PhospholipaseA2, a 
well-studied component resent in the venom of all poisonous snakes.   
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It affects electron chain transport of mitochondria by inhibiting 
cytochrome C enzyme.  RBC, WBC, platelets, vessel endothelium, 
muscle are damaged by this enzyme.  Myoneural junction and 
peripheral nerves are also affected. 
e. Ophio amino acid oxidase can activate proteases and peptides bound 
up in the cells. It hastens autolysis and putrefaction in viper venoms. 
f. Phosphodiesterase found in snake venoms, has been found to produce 
immediate and profound fall in the systemic arterial pressure. 
g. Arginine ester hydrolase present in crotalid and viper venoms, is 
coagulant in the effect and release bradykinin in the body. 
h. Acetyl choline present in cobra and crotalid venoms is shown to have 
direct action on the heart and neuromuscular junction. 
Hemotoxic effects of snake venoms27 
Viper venom is purely vasculotoxic. It causes rapid swelling, necrosis, 
and eventually produce dry gangrene by thrombosis of the blood vessels 
supplies that area.  Sytstemic absorption occurs through lymphatics and is slow 
produce lymphangitis.  Coagulation disturbance typical to viper venoms, which 
cause complications and death. 
Persistent bleeding from bite as well as from the cannula site indicates 
that coagulation mechanism has altered. Haemorrhage with altered capillary 
permeability produce pulmonary edema and profound shock.  Renal injury 
shows signs and symptoms of loin pain, hematuria, oliguria which are common 
before death. 
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Haemorrhagins-1 & 2 are non-enzymatic component found in viper 
venoms.  It rapidly causes lethal haemorrhage in many vital organs by 
destroying vascular endothelial lining and platelet functions.15 
a. Coagulant property of venom is mainly due to activation of 
thromboplastin, factor X and factor V. 
b. Anticoagulant effect is mainly from fibrinolysis, destruction of clotting 
factors. 
c. Proposed mechanisms of viper venom induced coagulopathy include.28 
Venom toxin behaves thrombin-like activity and acting on fibrinogen 
leading to fibrin formation. Platelet aggregating effect of the venom. 
    
 
 
 
 
 
 
 
 
Figure 11: a) Russell’s Fang marks 
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Figure 11:b) Local bleeding from bite site 
 
 
 
 
 
 
 
Figure : 12 (a) Haemorrhagic infarct of the anterior pituitary gland  
 
 
 
 
 
 
 
Figure : 12 (b) Patient bitten a Burmese Russell’s viper three years 
previously, showing signs of pan hypopituitarism:  [loss of pubic and 
axillary hair and testicular atrophy.] 
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Neurotoxic effects of snake venom29 
Krait, some type of cobras and coral snake cause mild local swelling. 
But naja naja produce painful local swelling, necrosis and blisters.  Local 
necrosis produces putrid order due to direct cytolysis effect which look like 
“wet gangrene”. Skip lesion are unique. Systemic absorption occurs via venous 
route and cause neurotoxic symptoms.  
The systemic signs and symptoms were nausea, vomiting, prostration, 
malaise, ptosis and opthalmoplegia herald the paralysis. Palsy of facial, neck, 
tongue and palatal muscles also noted. Death is due to respiratory failure.  
 
 
 
 
 
 
 
 
 
Figure: 12. Bilateral ptosis 
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Cardiotoxicity of snake venom30, 31 
Cardiac complications are usually not a prominent feature. They are due 
to a direct acting cardio toxin where in the symptoms appear rapidly within 30 
minutes to 2 hours. It has been reported to occur with both viper and elapid 
bites. Sudden hypotension, cardiac arrhythmias, cardiac arrest, peripheral 
circulatory failure and pulmonary oedema are the common clinical 
manifestations.15 
Nephrotoxic effects of snake venom32 
Acute renal failure (ARF) is characterized by fast and progressive 
decrease in renal function over a period of hours to days. Elevated plasma urea 
and creatinine concentrations confirm the diagnosis. ARF is usually associated 
with oliguria (24 h urine volume less than 400 ml) or anuria (24 h urine less 
than 100 ml), but this is not invariable. Some patients with ARF may have a 
normal urine output. 
Acute renal failure is common in vasculo toxic snake bite with an 
incidence rate of 14% to 33% following R.Viper / Saw Scaled Viper. The 
mechanism for ARF is also not clear the possible reasons are haemolysis, 
haemorrhage, shock, myoglobinuria and coagulation defects. 
Pathophysiology of Acute Renal Failure33-35 
The exact pathophysiology of ARF following snakebite in not well 
known. This is due to the lack of a reproducible animal model. 
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Hypotension 
Bleeding into tissue structures and external to the body with plasma loss 
produce circulatory collapse and hypotension. This is due to venom 
metaloproteinases which damage the basement membrane of vessel wall and 
disturb the integrity of  endothelial cell lining.  
In addition vasodilatation, unchecked capillary permeability, both are 
caused by direct/ indirect effect of venom. These two factors set a cascade of 
hemodynamic disturbance eventually leads to AKI.   
Intravascular-haemolysis36 
Intravascular haemolysis is due to activation of phospholipase A2.  This 
direct lytic factor hydrolyse the RBC cell membrane proteins directly.  This 
enzyme produce lysolecithin from serum lecithin, which also induce 
haemolysis. 
Disseminated intravascular coagulation37,38 
Homeostasis of coagulation system checked and balanced by cascade of 
vital reactions.  This venom toxin interacts and disturbs these pathway and 
produce abnormal coagulation pattern.This is particularly seen in viper 
families39. 
The anticoagulant effect of venom is attributed to protein-c activation.  
This protein cleaves Va, VIIIa (clotting factors) and inhibit factors X and IX 40. 
Directly-acting fibrinolytic proteins of the venom plays crucial role in the 
anticoagulation mechanism.   
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Zn-metaloproteinases (α/β  fibrinogenases)  is a main fibrinolytic 
enzyme involved in  D.I.C.  Platelet activated proteins is a toxin inhibit 
aggregation and stimulates activation of platelets. 
D.I.C.is a salient feature of victims bitten by viperidae species41. The 
deposition of fibrin clot in microvasculature, glomerular capillaries, MAHA 
(micro angiopathic hemolytic anemia), thrombocytopenia with renal cortical 
necrosis shows the role of disseminated intravascular coagulation in 
pathogenesis of AKI42, 43. 
Direct Nephrotoxicity44, 45  
Experimental studies in rabbits with venom toxins provide clues about 
renal glomerular lesions.  The common histological changes are acute 
tubular/cortical necrosis.  A good supportive evidence of direct nephrotoxicity 
is dose dependent decline of “inulin clearance” with “Fractional excretion of 
sodium” in an isolated perfused rat kidney.  The prominent morphological 
structural lesions were found mainly in cortex.  Glomerular epithelial, 
endothelial cell damage with ballooning and rupture of arterioles can be 
evident.46,47.  Hypersensitivity reactions, sepsis and myoglobulinuria also 
induce renal injury.  Myoglobulinuria commonly seen in sea snake bites 
resulting in muscle paralysis and necrosis. 
Renal Histology 
Acute tubular and cortical necrosis are the prominent histological 
features.  Other types of glomerular injuries are insignificant.   
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Acute Tubular Necrosis (ATN) 48, 49 
ATN-an important lesion found in 60 to 80% of victims with AKI.  
Light microscopy shows dilated tubules lined with flattened epithelium.  
Severe damage to tubules is evident by epithelial cell necrosis, desquamation 
of the cells from the basement membrane.  Brown pigment casts, hyaline casts 
seen in tubule lumen.   
Figure 13a & 13b: Histology of Acute Tubular Necrosis 
 
Inflammatory cell infiltration, oedema and haemorrhage are seen in 
interstitium. Intrarenal vessels are not involved.  Distal, proximal tubular cells 
demonstrate dense intracytoplasmic inclusion bodies, dilated endoplasmic 
reticulum (smooth and rough).  Apoptosis is severe in distal tubules while 
fibroblast hyperactivity is found in interstitium. 
Granulated/degranulated form of eosinophils and mast cells are seen in 
vascular smooth muscle cells.   
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The salient features of acute tubular necrosis in snake bite are 
a. Distal tubular apoptosis. 
b. Fibroblast hyperactivity of interstitium. 
c. Presence of eosinophils and mast cells in smooth muscle cells. 
d. Predominant vascular injury. 
Acute cortical necrosis50, 51 
Bilateral patchy/diffuse cortical necrosis is seen in saw scaled viper 
bites.  In India, cortical necrosis is quiet very common, but the reason is not 
clear.  These patients have fibrin clots in the arterioles.  A thin area below the 
subcapsular cortex escapes from necrosis, but area below this show severe 
necrosis.  Hyperemia, leukocyte infiltration are seen in acute phase of necrosis, 
but calcification occurs in chronic stage.  Organization of clot with fibroblastic 
proliferation occurs in healing process. 
Glomerular Lesions52,53 
Reports from few studies showed following types of glomerular 
changes can occur like proliferative glomerulonephritis, crescentic 
glomerulonephritis. These renal lesions have developed within 24-48 hours and 
ascribed to an allergic reaction to snake venom. Other glomerular changes 
observed are ballooning of arterioles, endothelial cells swelling, mesangiolysis 
and breach in glomerular basement membrane;. Immunofluorescence 
microscopy shows complement [C3], immunoglobulin [IGM] and fibrin clot 
deposits.54 
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Intense and Dense, mononuclear cell infiltratation in the interstitium, 
herald the acute interstitial nephritis. 
Clinical Features 
The clinical features of snake bite varied with  
1. Gender and age of the person  
2. Snake type 
3. Location of the bite area 
4. The amount and toxic nature of the venom 
Persons with dry bite manifest unique clinical signs.  Anxious person 
can hyper ventilate and develop dizziness.  They also have sensory disturbance 
[pin & needles] and spasm in the extremities.   
Some may develop vasovagal response with unconsciousness. Other 
develops anxiety and manifest wide range of wrong symptoms46.  
Mortality and Morbidity is high in extremes of age groups and also 
depend upon the physic of the casualty.  
Local Effects15 
Pain in bite location and few inflammations might be expected in all 
bites, the pain is most severe in viper bites. In case of elapid bites, patients 
often complain of burning sensation at the site. In the bitten limb, local 
increase in capillary permeability leads to swelling and bruising. Local tissue 
necrosis can occur either due to the toxic effect of the venom or to the 
complicating feature like arterial thrombosis, tourniquets. Regional 
lymphadenitis may also be noted.55  
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Secondary ulcers, chronic ulcers & osteomyelitis rarely occurs. 
Petechiae, ecchymosis, serous and hemorrhagic bullae are other local signs. 
Local manifestations usually present as cellulitis, edema, blister, erythema pain 
&tenderness with local rise of temperature at the bite area. 
Systemic Effects 
This can be divided into: 
 Neurotoxic Effects 
 Hemotoxic Effects 
 Cardiotoxic Effects 
 Nephrotoxic Effects 
 Other complications such as shock 
Neurotoxicity34 
Confined to cobra, krait and sea snake bites, the symptoms of 
neurotoxicity appear from 20 minutes to 15 hours of the bite. According to the 
extent of envenomation, the symptoms may progress insidiously or rapidly to 
coma. Ptosis, varying degrees of ophthalmoplegia, palatal palsy, and 
pharyngeal paralysis with dysphagia, dysphonia, respiratory paralysis and 
flaccid limb paralysis are the common presentations with the advent of 
respiratory paralysis, hyoxaemia, drowsiness, convulsions and coma can ensue. 
The symptoms may progress slowly or fastlyto coma depending upon the 
envenomation spread. 
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Hemotoxicity 
Hypofibrinogenemia and DIC are the main reason for in coagulation of 
blood and is the salient feature of systemic envenomation in wide spread 
geographical areas. Clinically, features of defective hemostasis include 
bleeding from the bite site and from cannula puncture sites, at other area of 
wound and from partially healed injuries in the body.56,57 Common 
manifestations of spontaneous systemic bleeding includes, hematuria, 
gastrointestinal bleeding (hematemesis and melena), gingival bleeding, 
hemoptysis and cutaneous bleeding in the form of purpura and ecchymosis. 
Less common are menorrhagia and Central Nervous System bleeding. 
Subarachnoid hemorrhages / Intracranial hemorrhanges are most important 
reason for death. Pituitary and adrenal hemorrhage has also been reported. 
Bleeding may be prolonged and last as long as 26 days or more.58 Other 
important feature is (DIC) which may either manifest as bleeding or 
thrombosis, with resultant ischemia. Intravascular hemolysis may also occur 
and result in hemoglobinuria and jaundice if it is massive. Hemotoxicity is said 
to be present if the patient’s bleeding time is more than 8 minutes, prothrombin 
time more than 16seconds or the clotting time more than 30 minutes or if there 
is abnormal lysis of clot. 
Nephrotoxicity59, 60 
In victims with Acute Kidney Injury, oliguria / anuria frequently& 
quickly develops within the one day, but may be delayed till 48 to 72 hours 
after the snake bite. Few will have anuria, and rarely nonoliguric.  
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Urine analysis study might manifest microscopic or gross hematuria i.,e 
blood in Urine. Some victims experiences of pain in the loin with absence of 
urine output.  This symptom indicates development of renal failure. Within 
next few days Blood pressure level considerably elevated with the absence of 
urine output and symptoms of kidney failure.  Kidney failure symptoms 
(drowsiness, irritability, vomiting, hiccups, acidotic breathing, pericardial rub, 
convulsions) occur within 3 to 7 days of snake bites.61Nephrotoxicity 
diagnosed as acute renal failure when there is acute rise of serum creatinine to 
more than            1.5 mg /dl. 
Other Manifestations 
There may be features of increased capillary permeability which may 
appear within 24 hours of bite. These may be generalized, and lead to 
conjunctival, facial oedema, serous effusions in pleural cavity and abdominal 
cavity and radiological or clinical substantiation of pulmonary oedema. 
However, these are common following viper bites in Burma and Thailand and 
rarely seen in India. Rhabdomyolysis may rarely be seen and lead to 
generalized muscle aching, muscle tenderness and passage of dark red or black 
urine due to myoglobinuria. Arterial thrombosis, shock, necrosis of the limb, 
tetanus, and abortion in pregnant women are also seen after snake bite.15 
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Chronic complications62 
Below complications may occur after snake bite 
1. Tissue loss following infection and sloughing  
2. Surgical wound debridement of the bite site 
3. Amputation of affected part  
4. Chronic non healing ulcer 
5. Bone Infections [Osteomyelitis] 
6. Neoplastic conversion might happened due to non-healing skin ulcers 
 
 
 
 
 
 
Figure: 14a Physical disability&disfigurement due to poisonous snake bite 
 
 
 
 
 
 
Figure: 14b Physical disability&disfigurement due to poisonous snake bite 
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Figure:15 Neoplastic conversion  of a chronic skin ulcer with osteomyelitis 
few years after a bite by a poisonous viper. 
 
Investigations 
Laboratory investigations for snake bites envenomation have less 
sensitivity and specificity. They are actually useful to take decision for 
appropriate intervention63.  
There are two types of investigations as below  
1. Specific  
2. Non- Specific 
1. Specific 
(a) The 20-min whole blood clotting test (20 WBCT) 
Simple and routinely use blood test for the diagnosis of coagulopathy is 
20 minutes whole blood clotting time test.  This is performed in a dry, clean 
glass tube which should not be washed with any cleansing agent.   
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Venous blood withdrawn from the patient is transferred to this tube and 
kept undisturbed for twenty minutes.   
Blood should be clotted in twenty minutes if there is no envenomation.  
If not clotted it indicates coagulopathy and venom should from Viper64 
(b) Enzyme linked immunosorbent assay (ELISA) 
This test is very costly and available only in few sophisticated centres.  
It is mainly used to find out the species by using antigens of snake venom. So 
it is very useful in epidemiological surveys. 
 
2. Non-Specific  
a. Urine Analysis 
It reveals  
1. Albuminuria 
2. Myoglobinuria 
3. Hematuria 
4. Hemoglobinuria    
b. Complete Hemogram 
 1. HB – Pallor - > indicates Hemolysis 
 2.   PCV - > indicates hemoconcentration and plasma leak. 
 3. Leucocytosis [Neutrophils] - >Signifies systemic envenomation. 
 4. Thrombocytopenia  
c. Prothrombin time 
 PT – Prolonged [Viper bite] 
34 
 
d. Activated partial thromboplastin time 
 aPTT – Prolonged [Viper bite] 
e. Fibrin degradation products 
 FDP – Elevated 
f. Renal Function Test 
 Bun and creatinine – Elevated - > indicate renal injury 
g. ABG Analysis  
h. Electrolytes 
i. ECG 
Useful in diagnosis of brady/tachyarrthymias 
j. EEG 
EEG changes are absorbed in nine out of ten victims shortly after the 
snake bite.  These wave pattern arises from temporal lobes, and is not 
associated with development of encephalopathy.68 
k. Blood Grouping & Typing  
 
Snake Bite Management 
World Health Organization along with S.E.A.R.O have released a 
protocol for the approach and management for snakebite induced 
envenomation66.  These principles are accepted worldwide.  The guidelines are 
published in the journal for Tropical Medicine and Public Health of South East 
Asia.66 
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First Aid68 
The goal of first aid is to delay the systemic envenomation and abolish 
lethal sequealae by early transfer of victim to the medical care centre.  All 
cultural taboos are discouraged because they worsen the situation.  Somebody 
apply tourniquet as a first aid. 
Give reassurance to the patient because most of the bites are dry.  Apply 
splints and immobilize the affected part and finally transport the victim to 
medical centre. 
PIM 
Pressure immobilization method (PIM) has primarily developed and 
adapted by the University of Melbourne in Australia (venom research unit).  
This technique encourages immobilization of the affected part by applying 
splint or bandages. Once the splint has applied, the part should not be 
mobilized.  Otherwise, the technique is ineffective.  Health education to health 
workers, community health providers, and civilians is essential regarding early 
immobilization and safe transfer of patient to the hospital. 
Hospital Management 
In the emergency department, the patient should be assessed for airway, 
circulation, breathing, and level of consciousness. Immediate attention to be 
given to patient with shock, respiratory failure, and with altered 
sensorium/unconsciousness. O2 is mandatory to all patients with 
envenomation.  IV access with wide bored cannula is also important.  Isotonic 
fluid like RL/NS should be infused to prevent shock. 
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History 
First confirm whether the victim had a snake bite or some other bite 
made by other animals.  Once you confirmed, then search for the fang marks 
and local signs of envenomation.  History about time interval between the bite 
and hospital admission is essential.  Other detailed history regarding 
comorbidity, allergy, adverse drug reactions, systemic illness also essential.6 If 
the patient had brought the snake, careful examination and identification is 
important.  A very quiet interesting is crotalids envenomate even after death. 
General Examination6 
Patient consciousness, orientation and vitals should be assessed first.  
Then, examine the bite area and search for local signs like pain, swelling, 
bleeding, and cellulitis.  Limb circumference should be calculated at frequent 
intervals to assess the progression of cellulitis. 
The list given below is useful to assess the severity of envenomation 
1. Snake type – venomous/nonvenomous. 
2. Rapid progression of cellulitis.   
3. Palpable, tender, lymph node enlargement, draining the affected 
part. 
4. Rapid onset of systemic symptoms. 
5. Spontaneous and massive bleeding. 
6. Altered urine colour (hemoglobulinuria). 
7. Absence of peripheral pulses (compartment syndrome).  
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Specific Therapy 
Anti snake Venom68 
Anti snake venom is the specific antidote for venom of snakes.  It is an 
immunoglobulin derived from immunized equine serum.  First venom is given 
to the horse and immunized, then immunoglobulin’s are extracted and purified.   
 
 
 
 
 
 
 
 
 
Figure 16 ASV Vial 
Two types of ASV are available.   
1.  Monovalent.   
2.  Polyvalent. 
The main disadvantages of monovalent ASV are price, less availability, 
and it require species confirmation73. The advantages of polyvalent ASV are 
cheaper, wider availability, and Para specific activity (antibodies developed 
against venom of one type of snake neutralize the other type of snake venom). 
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There are two forms of ASV available. 1.  Liquid form  2.  Lyophilized form 
1. Liquid form – Cold chain is mandatory, cost effective, high chances of 
physicochemical changes. 
2. Lyophilized form – Cold chain is not required, costly, and stable.  
Lyophilized form is reconstituted by the method of swirling with 10 ml 
of N.S. 
Manufacturing Units in India 
1. Central Research Institute – Himachal Pradesh (Kasauli). 
2. Haffkine Corporation – Maharashtra (Mumbai).  
THE CROFAB (crotalidae immune Fab) 
FDA has recently approved the use of CROFAB for the crotalidae 
envenomation.  This crofab binds with fab site of IgG immunoglobulin.  This 
immune fab acts in three ways.  One is to neutralize the toxin.  The second one 
favour the redistribution of venom from the affected tissues and the final one 
facilitate its elimination from the body circulation. The incidence of acute and 
late allergic responses to this product is comparatively lower than the regular 
antivenom.   
Indications For ASV73 
Antivenom therapy is indicated with every patient who shows severe 
systemic and local toxicities.  ASV administration is associated with high 
chances of adverse reactions.  It is costly and is not very well available in many 
areas, so pros and cons to be weighed before initiation of treatment. 
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1. Systemic Toxicity74, 75 
a. Haematological abnormalities – WBCT more than 20 minutes, 
spontaneous bleeding, low platelet count. 
b. Neurotoxicity -Ophthalmoplegia, bulbar palsy, etc. 
c. Cardiovascular- Hypotension, acute pulmonary oedema, circulatory 
collapse, dysrhythmia. 
d. Severe rhabdomyolysis. 
e. Acute kidney injury. 
2. Local Envenomation 
a. Rapidly evolving cellulitis. 
b. Cellulitis affecting more than half of the involved extremities. 
c. Severe bruising and blistering.   
d. Victims bitten by spices which cause severe local necrosis. 
Contraindications for ASV66 
There are no relative or absolute contra indications for ASV 
administrations, though, it is used very carefully by a person who has atopic 
history and showed immune response to equine antisera. Pregnancy is not a 
contra indication. 
Antivenom [ASV] Therapy 
It is ideal to start ASV before four hours from the time of bite, ASV can 
effective within a day of bite.  
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Dose of ASV 76 
Till now there is no evidence based on clinical trials for ASV dosage.  
In India we determine the dosage depends on the   severity of envenomation. 
 
 
 
 
 
 
 
 
Figure 17 Milking of Venom 
 
Regional Office of South East Asia for World Health Organization 
strongly suggest the quantity of antivenom to offset  based on the average 
venom yield by a captive snakes are milked.71  In India we determine the 
dosage depends on the degree of envenomation.  Usually Russell’s viper 
delivers approximately Sixty Three milligrams of venom with the standard 
deviation of plus or minus Seven milligram per maiden bite. 77,78     
One polyvalent vial neutralizes Six milligram of Russell’s Viper 
Venom, so each and everyone should be given Eight to Ten vials primarily. 
There is no dosage difference between Child and Adult. Because snakes 
always delivers same quantity of venom.66 
41 
 
Response is evident by reversal of normal BP.80 Bleeding arrest should 
happen within half an hour, reversal of coagulopathy occurs more or less six 
hours to regularize.  However Neurotoxicity symptoms improves within half 
an hour but it may take 1 to 2 days for complete retrieval.81 
Repeated dosage of ASV must be given if there is irreversibility of 
coagulopathy persistence more than six hours or bleed continuously beyond 
one to two hour of the initial dosage.  It is necessary to repeat the dosage if 
signs of neurotoxic or cardiotoxic are worsening even after the one to two 
hours.66 
ASV Administration 
ASV administration can handle in 2 different ways.  
1. Intravenous infusion – Five to Ten milligram per Kg body weight of 
diluted antivenom 
2. Slow Intravenous infusion – Dosage at a rate of 2 ml per minute. All 
patients has to be monitored for a period of minimum 60 minutes for 
progress of anaphylaxis 
ASV should not be injected directly in the snake bitten place, because 
this kind of administration develop major risk like intolerable pain and increase 
pressure in intra compartmental region. 
Intramuscular injections are not advisable, because it has large 
molecules.  This large molecule spreads slowly thorough lymphatics and 
impaires the bio availability.  
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This route of administration also causes sciatic nerve injury and 
hematoma formation. 66   Injection adrenaline should be kept ready before ASV 
administration. 
ASV Sensitivity Testing 
ASV sensitivity testing is not at all recommended, because not able to 
foresee the development of either early reactions which is anaphylactic or late 
reactions which is Serum sickness.66 
This testing allows the patient for the exposure of serum protein with 
development of reaction further delays the treatment.  
ASV Reaction 
There are two types of ASV reaction, they are as below  
a. Early  
b. Late 
ASV does not develop any reaction for approximately 75-80% of 
patients, i.e it develop reactions to the 20-25% of patients. Approximately 20% 
patients treated with ASV develop either early or late reaction.66 
Early Reactions 
Early reactions happens within One Hundred and Eighty minutes from 
the time of treatment started and it develops below characterization 
1. Itching. 
2. Urticaria. 
3. Dry Cough. 
4. Nausea & Vomiting. 
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5. Abdominal Colic. 
6. Diarrhea. 
7. Tachycardia.  
8. Fever. 
9. Hypotension.  
10. Bronchospasm. 
11. Angioedema. 
Late Reactions 
Late reactions develop between one and twelve days [Average 7 Days] 
from the date of treatment.  Clinical features are 
1. Fever. 
2. Nausea. 
3. Vomiting. 
4. Diarrhea. 
5. Itching. 
6. Recurrent Urticaria. 
7. Arthralgia. 
8. Myalgia. 
9. Lymphadenopathy.  
10. Immune complex nephritis.  
11. Encephalopathy [Very Rarely]. 
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Pyrogenic Reactions 
It happens due to manufacturing defects or contamination of Antivenom 
by pyrogens, normally it become evident within two hours from the time of 
treatment. Symptoms are as below  
1. Chills and rigors. 
2. High grade fever. 
3. Hypotension. 
Treatment For ASV Reaction 
Treatment for ASV reaction is below [Early] 
1. Adrenaline 
2. Antihistamine  
3. Glucocorticoid 
Adrenaline 
 Adult Dosage - 0.50 milligram [One in Thousand dilution] - > Route – 
intramuscular 
 Child Dosage - 0.01 milligram per Kilogram body weight - > Route - 
intramuscular 
Antihistamine [Chlorpheniramine maleate] 
 Adult Dosage - 10 milligram - > Route - intravenous 
 Child Dosage - 0.02 milligram per Kilogram body weight - > Route – 
intravenous 
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Glucocorticoid [Hydrocortisone] 
 Adult Dosage - 100 milligram - > Route - intravenous 
 Child Dosage – 2 milligram per Kilogram body weight - > Route – 
intravenous 
Treatment for ASV reaction is below [Late] 
1. Antihistamine  
2. Glucocorticoid 
Antihistamine [Chlorpheniramine maleate] 
 Adult Dosage - 2 milligram every six hours - > Route - Oral 
 Child Dosage - 0.25 milligram per Kilogram body weight divided dose - 
> Route – Oral 
Glucocorticoid [Prednisolone] 
 Adult Dosage - 5 milligram every six hours - > Route - Oral 
 Child Dosage – 0.7 milligram per Kilogram body weight divided dose- 
> Route – Oral 
 
Supportive Treatment 
The Patient, who envenomed severely, should be admitted in Intensive 
Care Unit. Patients who have not severely envenomed can be admitted in the 
ward and monitoring to be happened closely. 
46 
 
Patients who envenomed severely can be identified from the below any 
of the symptoms 
a. Coma. 
b. Respiratory paralysis. 
c. Hypotension. 
d. Pulmonary edema. 
e. Syncope. 
Supportive therapy is essential buy time till the time recovery of the 
damaged organs. 
Different types of supportive methods as summarized below 
Management for Coagulopathy71 
ASV plays crucial role in the correction of Coagulopathy.  Once ASV 
has given Coagulopathy immediately reverses.  In unique cases with severe 
uncontrolled bleeding, the following can be given to reverse the Coagulopathy. 
1. Fresh whole blood 
2. Cryoprecipitate 
3. Fresh frozen plasma 
4. Platelet concentrates 
Management for Renal Failure 66 
Renal failure is more common in victims who are envenomed with 
viperiade family.  Renal perfusion can be improved by following ways. 
a. IV fluids – Isotonic saline 
b. Diuretics – Furosemide (up to 100 milligram) 
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c. Dopamine – 2 microgram per Kg per minute 
Once patient develops oliguria for the period of more than 6 hours or 
anuria the following should be done.   
1. Central venous catheter insertion.  
2. Urethral catheterization. 
3. Fluid balance monitoring. 
If myoglobinuria / hemoglobinurea developed the following should be 
done to prevent Kidney damage. 
1. Isotonic IV fluids [Hypovolemia] 
2. Injection mannitol [Urine Production] 
3. Bicarbonate [Acidosis] 
Management for Neurotoxicity82 
Even though antivenom therapy is indicated, patient with bulbar palsy 
as well as respiratory failure should be given other line of treatment. The 
earlier signs of severe neurotoxicity are as follows  
a. Slurring of speech. 
b. Regurgitation of fluids. 
c. Poor Cough response. 
d. Motor Paralysis.  
e. Poor respiratory effort. 
The patient with the above symptoms should be intubated and supported 
with mechanical ventilation.  The Neurotoxins affects the Myoneural junction 
and its activity.  Its activity is reversed by anticholinesterase. 
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Anticholinesterase [Neostigmine] 82 
 Initial Dose - 0.5 milligram – Every 30 minutes – Route - > Intra 
venous – 5 Doses 
 Repeat  dose  - 0.5 milligram – gap of 2 -12 Hours - Route - > Intra 
venous 
Atropine82 
Dose – 0.6 milligram – Route - > IV [before each time of Neostigmine] 
Disanayake et al82 did a prospective study in Neurotoxin envenomation and 
they recommend Neostigmine in two situations. 
a. Positive Tensilon test 
b. Decremental response to repetitive nerve stimulation. 
Management of cellulitis83 
1. Limb elevation and immobilization  
2. Cellulitis has been treated with broad spectrum of antimicrobial agents 
which covers gram positive and gram negative organisms and anaerobic 
agents.   
3. Fasciotomy should be considered with the development of compartment 
syndrome.  The signs and symptoms of compartment syndrome are 
vague. So diagnosis is difficult.  However we can diagnosis by 
monomeric technic. 22 gauge needle is inserted at the affected site and it 
is connected to the manometer device.  If pressure is more than 55 
centimeter of H2O diagnosis is confirmed.  
4. Fasciotomy  might be delayed until reversal of coagulopathy symptoms, 
otherwise it endangers the life. Tetanus Toxoid.71 
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MATERIALS AND METHODS 
Study Group: 
100 Snake bite patients admitted in Medical ward, Government Vellore 
Medical College Hospital, Vellore. 
Study Design: 
Clinical, prospective and observational study  
Study Population: 
This study was conducted among 100 patients who were admitted in 
medical ward Govt. Vellore medical college hospital, Vellore. 
Duration of Study: 
1 year (August ‘2014– July’2015) 
Inclusion Criteria:   
1. Features suggestive of snake bite with or without local and systemic 
envenomation. 
2. Definite fang marks noted. 
3. Patients or attenders have seen the offending snake. 
4. Progressive increase in serum creatinine more than “0.3mg/dl” from 
baseline, a percentage increase in the serum creatinine concentration of 
more than 50% (or) oliguria of less than 0.5ml per kg per hour for more 
than 6 hours. 
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Exclusion Criteria: 
Patients with history of suspected snake bite, where in 
1. Patient or attenders have not seen the snake. 
2. Patient with pre-existing renal disease. 
3. Patient with risk factors for developing renal diseases with history of 
snake bite (Diabetes mellitus, systemic hypertension, connective tissue 
diseases) 
Data Collection: 
           All patients confirmed of snake bite will be selected and subjected to 
detailed history, physical examination and biochemical test with special 
reference to renal involvement. Special tests like bleeding time, clotting time, 
serum electrolytes and USG abdomen was done whenever necessary. Systolic 
Blood pressure <90mmHg is considered as hypotension. 
Patients were followed up till discharge or death. They were treated 
accordingly. Clinical data was tabulated. Statistical analysis was done. 
Statistical Analysis: 
All statistical analysis were performed using the SPSS (Software 
package used for statistical analysis) package. A “P” value of less than 0.05 
was considered to be statistically significant. 
Collaborative Department:   
BIOCHEMISTRY & NEPHROLOGY 
Consent:  
Individual written and informed consent 
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Ethical Clearance:  
Obtained from “ETHICAL COMMITEE” Government Vellore Medical 
College, Vellore 
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RESULTS 
A prospective clinical study of 100 patients of snake bite from August 
2014 to July 2015 was done to know the clinical profile and outcome in 
GVMCH, Vellore.  
 
TABLE 1 : AGE AND GENDER DISTRIBUTION 
Age 
Male Female 
Number Percentage Number Percentage 
13-20 yrs 8 11.7% 2 6.3% 
21-30 yrs 10 14.7% 7 21.8% 
31-40 yrs 15 22.1% 13 40.6% 
41-50 yrs 17 25% 6 18.8% 
51-60 yrs 11 16.2% 3 9.4% 
> 60 yrs 7 10.3% 1 3.1% 
TOTAL 68 100% 32 100% 
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FIGURE 18: AGE AND GENDER DISTRIBUTION 
 
 
Maximum incidence of snake bite occurred in the age group between 31 
and 40 years (28%) followed by 41-50 years (23%). 
Males are more commonly affected (68%) than females (32%). 
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TABLE 2:  PREMISE OF BITE 
PREMISE OF BITE NUMBER 
INDOOR 89 
OUTDOOR 11 
 
 
FIGURE 19: PIE CHART SHOWING PREMISE OF BITE 
 
 Most of the bites occurred in outdoor. (89%) 
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TABLE 3:  SITE OF BITE 
SITE OF BITE NUMBER 
LOWER LIMB 64 
UPPER LIMB 30 
OTHER SITE 6 
 
FIGURE 20: PIE CHART SHOWING SITE OF BITE 
 
 
 
 
 
 
 
 
 
 
 
Lower limb (64%) is the most common site for snake bite followed by      
Upper limb (30%) and other sites (6%). 
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TABLE 4:  APPLICATION OF TOURNIQUET 
TOURNIQUET NUMBER 
APPLIED 78 
NOT APPLIED 22 
 
FIGURE 21: PIE CHART SHOWING APPLICATION OF 
TOURNIQUET 
 
Majority of the victims had applied tourniquet. (78%) 
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TABLE 5: TYPE OF SNAKE 
TYPE OF SNAKE NUMBER 
UNIDENTIFIED 63 
VIPER 29 
COBRA 7 
KRAIT 1 
 
FIGURE 22: BAR DIAGRAM SHOWING TYPE OF SNAKE 
 
Among 37 cases in which snake was identified, bites due to Viper (29) 
were most common followed by Cobra(7) and Krait(1). 63 patients could not 
identify the snake. 
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TABLE 6:  TIME LAG IN HOSPITALIZATION OF PATIENTS 
TIME LAG TO HOSPITALISATION NUMBER 
< 2 hours 21 
2-4 hours 24 
4-6 hours 18 
6-12 hours 20 
12-24 hours 12 
> 24 hours 5 
 
FIGURE 23: BAR DIAGRAM SHOWING TIME LAG IN 
HOSPITALIZATION OF PATIENT 
 
Majority of patients reported within 4 hours of the bite (45). 18 patients 
presented within 4-6 hours while 32 patients presented within 6-24 hours. 5 
patients presented after 24 hours of the bite. 
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TABLE 7: TOTAL NUMBER OF ASV IN VIALS 
ASV IN VIALS NUMBER OF PATIENTS 
1 To 10 19 
11 To 20 54 
21 To 30 27 
 
FIGURE 24: TOTAL NUMBER OF ASV IN VIALS 
 
54 patients received about 11-20 vials and 27 patients received 21-30 
vials rest of 19 patient received 1-10 vials  
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TABLE 8: DURATION OF STAY IN WARD 
Duration of 
stay in days 
Male Female  
Total No No 
1-2 2 0 2 
3-4 33 12 45 
5-6 18 12 30 
7-9 12 8 20 
10 & above 3 0 3 
Total 68 32 100 
 
FIGURE 25: DURATION OF STAY IN WARD 
 
Majority of patients stayed in the hospital for 3 to 4 days (45%) and 
only 3% stayed in the ward more than 10 days. 
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TABLE 9: LOCAL MANIFESTATION OF ENVENOMATION 
Local 
Manifestation 
Male Female Total 
No No No 
Pain 68 31 99 
Swelling 55 26 81 
Cellulitis 17 9 26 
 
FIGURE 26: LOCAL MANIFESTATION OF ENVENOMATION 
 
Among local manifestation (99%) of patient experienced pain followed 
by swelling (81%) and cellulitis (26%) 
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TABLE 10: NEUROTOXIC MANIFESTATION OF ENVENOMATION 
Neurotoxic 
Manifestation 
Male Female Total 
No No No 
Ptosis 22 9 31 
Ophthalmoplegia 22 9 31 
Pharyngeal paralysis 7 1 8 
Respiratory Paralysis 4 2 6 
Motor Paralysis 5 0 5 
 
FIGURE 27: NEUROTOXIC MANIFESTATION OF ENVENOMATION 
 
Among 100 patients of snake bite, 81 patients developed neurotoxicity, 
31 patients developed ptosis, 31 patients developed of opthalmoplegia and 6 
patients developed respiratory paralysis. 
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TABLE 11: HEMOTOXIC MANIFESTATION OF ENVENOMATION 
Hemotoxic 
Manifestation 
Male Female Total 
No No No 
Bleeding from bite site 
(H1) 41 19 60 
Mucosal Bleeding (H2) 23 11 34 
Epistaxis (H3) 8 2 10 
Petechiae (H4) 2 0 2 
Hematuria (H5) 19 7 26 
Hematemesis (H6) 8 3 11 
Hemoptysis (H7) 10 6 16 
 
FIGURE 28: HEMOTOXIC MANIFESTATION OF ENVENOMATION 
 
 
 
 
 
 
 
 
 
60 patients developed bleeding from bite site, followed by 34 patients 
developed mucosal bleeding. 26 patients presented with hematuria. 
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TABLE 12: BLOOD PRESSURE VALUE 
BLOOD PRESSURE Total % 
Normal 85 85 
Hypotension 15 15 
 
FIGURE 29: BLOOD PRESSURE VALUE 
 
Among 100 cases 15 cases developed hypotension 
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TABLE 13: URINE OUTPUT 
 
URINE OUTPUT 
Male Female 
 
Total 
No No 
Normal 53 27 80 
Oliguria/Anuria 15 5 20 
 
FIGURE 30: URINE OUTPUT 
 
Among 100 patients 20 patients developed oliguria. 
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TABLE 14: PATIENT NEEDED FASCIOTOMY 
Fasciotomy Number  Percentage 
Done 7 7 
Not Required 93 93 
 
 
FIGURE 31: PATIENT NEEDED FASCIOTOMY 
 
 
 
 
 
 
 
 
 
 
 
Among 100 patients 7 needed fasciotomy. 
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TABLE 15: PATIENTS NEEDED DIALYSIS 
Hemodialysis Number  Percentage 
Done 5 5 
Not Required 95 95 
 
FIGURE 32: PATIENTS NEEDED DIALYSIS 
 
 
Out of 100 patients 5 needed hemodialysis. 
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TABLE 16: OUTCOME OF PATIENTS WITH SNAKE BITE 
Outcome Number Percentage 
Complete Recovery 98 98 
Mortality 2 2 
 
FIGURE 33: OUTCOME OF PATIENTS WITH SNAKE BITE 
 
Out of 100 patients only 2 patients were went to mortality and 
remaining 98 patients recovered completely. 
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TABLE 17: LEVELS OF SERUM CREATININE 
Creatinine values of Ist day and IInd day 
 
 N Range Minimum Maximum Mean Std. Deviation p 
CR Day1 100 1.6000 .6000 2.2000 .874000 .2866103 0.000 
CR Day2 100 3.3000 .7000 4.0000 1.185000 .6484441  
Valid N 
(listwise) 100       
 
There exists statistical significance between Ist day and IInd day 
creatinine values P value <0.0001. 
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TABLE 18: PLOTTING CREATININE LEVEL Vs OLIGUIRIA 
CREATININE 
OLIGUIRIA 
Yes No 
Elevated 17 (85%) 0 (0%) 
Not Elevated 3 (15%) 80(100%) 
Total 20 (100%) 80(100%) 
 
Sensitivity = 85% 
Specificity = 100% 
Positive Predictive Value = 100% 
Negative Predictive Value = 93.69% 
Diagnostic accuracy = 97% 
Kappa agreement = 0.901 
MC. Nemar (Paired test) P = 0.250 
We have tested creatinine with respect to oliguria and found that 85% 
sensitivity, 100% specificity and diagnostic accuracy 97%. We also seen kappa 
measure of agreement between creatinine based renal failure and oliguria based 
renal failure and value is 0.901, which is almost agreement between two. 
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TABLE 19: PLOTTING RENAL FUNCTION Vs GENDER 
 
 
 
 
 
 
 
 
Gender 
Renal Failure 
Yes No 
Male 15 (75%) 53 (66.3%) 
Female 5 (25%) 27 (33.8%) 
Total 20 (100%) 80 (100%) 
Chi-square = 0.563 
P Value = 0.4531 
Odds ratio = 1.528 
There is no statistical significant between renal failure and normal 
outcome patients with respect to gender. Among renal failure patients 75% 
were male.  If a patient is a male, there is 1.528 times an odds than female to 
get oliguria. 
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TABLE 20: PLOTTING RENAL FUNCTION Vs TIME LAG 
Time Lag 
Renal Failure 
Yes No 
>5 Hours 16 (80%) 27 (33.8%) 
≤ 5 Hours 4 (20%) 53 (66.3%) 
Total 20 (100%) 80 (100%) 
 
Chi-square = 13.96 
P Value < 0.0001 
Odds ratio = 7.852 
There exists a statistical significance between renal failure and normal 
patient with respect to time lag between > 5 Hrs (delayed) and ≤ 5 Hrs. 
Patients who were brought to hospital > 5 hours for treatment have an 
odds of 7.852 times than others for getting renal failure. 
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TABLE 21: PLOTTING RENAL FUNCTION Vs WBCT 
 
WBCT 
Renal Failure 
Yes No 
> 20 Minutes 19 (95%) 51 (63.8%) 
≤ 20 Minutes 1 (5%) 29 (36.3%) 
Total 20 (100%) 80 (100%) 
 
Chi-square = 7.44 
P Value = 0.006377 
Odds ratio = 10.8 
There exists a statistical significance between renal failure and normal 
patients with respect to WBCT > 20 and WBCT ≤ 20 Minutes. 
The patients those who are having WBCT > 20 Minutes are having 10.8 
odds than WBCT ≤ 20 Minutes for getting renal failure. 
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TABLE 22: PLOTTING RENAL FUNTION Vs HYPOTENSION 
Blood Pressure 
Renal Failure 
Yes No 
Hypotension 14 (70%) 1 (1.3%) 
Normal 6 (30%) 79 (98.8%) 
Total 20 (100%) 80 (100%) 
 
Chi-square = 59.31 
P Value < 0.0001 
Odds ratio = 184.3 
There exists a statistical significance between renal failure and normal 
patients with respect to hypotension / Normal. 
The patients those who are hypotensive are having 184.3 odds than 
normotensive to get renal failure. 
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TABLE 23: PLOTTING RENAL FUNCTION Vs CELLULITIS 
 
CELLULITIS 
Renal Failure 
Yes No 
Present 19 (95%) 7 (8.8%) 
Absent 1 (5%) 73 (91.2%) 
Total 20 (100%) 80 (100%) 
 
Chi-square = 61.86 
P Value < 0.0001 
Odds ratio = 198.1 
There exists a statistical significance between renal failure and normal 
patients with respect to cellulitis. 
The patients with cellulitis are having 198.1 odds than non – cellulitis 
patients to get renal failure. 
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TABLE 24: PLOTTING RENAL FUNCTION Vs HEMATURIA 
Hematuria 
Renal Failure 
Yes No 
Present 18 (90%) 8 (10%) 
Absent 2 (10%) 72 (90%) 
Total 20 (100%) 80 (100%) 
 
Chi-square = 53.22 
P Value < 0.0001 
Odds ratio = 81 
There exists a statistical significance between renal failure and normal 
patients with respect to hematuria Present/Absent. 
The patients with hematuria are having 81 odds than non-hematuria 
patients for getting renal failure. 
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DISCUSSION 
1. AGE OF THE PATIENT 
Table 25: Comparison of Age Group in Various Studies 
Age in years Nishioka59 Hati10 Present study 
21-30 21.6% 38.4% 17% 
31-40 17.5% 18.9% 28% 
41-50 10.6% 12.1% 23% 
51-60 7.5% 4.9% 14% 
Above 60 2.4% 4.2% 8% 
 
Study done by Nishioka et al59 had (17.5%) and Hati et al10 had (18.9%) 
of snake bite in the age group between 31-40 years but in my study (28%) of 
patients were in this age group. 
GENDER OF THE PATIENT 
Table 26: Comparison of Gender Incidence in Various Studies 
Gender Banerjee79 Sawai78 Present study 
Male 75% 66% 68% 
Female 25% 33% 32% 
 
In the present study incidence of snake bite were male (68%) and 
female (32%) as comparable with Sawai et al78. 
Males were the victims for snake bites more often than females in all 
studies including the present study. Agricultural labour is carried out 
predominantly by males and hence they are at risk. 
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SITE OF SNAKE BITE 
Table 27: Comparison of site of bite in various studies 
Site Banerjee79 Sawai78 Present study 
Lower limb 62.4% 67.8% 64% 
Upper limb 24.5% 25.2% 30% 
 
Most of the snake bites were observed in lower limb, followed by upper 
limb in all the above mentioned studies including the present study. 
TIME LAG IN HOSPITALIZATION 
Table 28: Lapse of time > 5 Hours in presenting to the hospital 
Studies Percentage 
Patil BT et al84 42% 
Athappan G et al80 55% 
Present study 55% 
 
In the present study 55% patients reported to the hospital >5 hours as 
comparable with Athappan series (55%). 
Early hospitalization below 5 hours was shown to reduce the incidence 
of morbidity & mortality and also decreased the duration of hospital stay. 
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LOCAL ENVENOMATION 
Table 29: Comparison of symptoms with other studies 
Symptoms Athappan G et al80 Present study 
Signs of inflammation 98.7% 99% 
 
Signs of inflammation in the present study were 99% which is 
comparable with Athappan et al80 . In the present study pain was noted in 99% 
of the cases, 81% cases showed swelling, similar to Mishra’s series38 (100%) 
and Sarangi’s series55 (84%). 
WHOLE BLOOD CLOTTING TIME 
Table 30: Comparison of WBCT > 20 Mins with other study 
Studies Present study 
Paul J Dasgupta et al83 74% 
Present study 70% 
 
     WBCT >20 Mins  is comparable with the study of Paul J Dasgupta et al83. 
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ACUTE RENAL FAILURE IN SNAKE BITE 
Table 31: Comparison of ARF in various studies 
 Srilatha et al64 Chugh et al65 Present study 
ARF 34% 28.8% 20% 
 
The incidence of ARF in srilatha  et al64 was 34% and chugh et al was 
28.8% but in my study it is 20%. 
SIGNIFICANT VARIABLES 
Table 32: Variables with significant p-value for the development of 
Snake bite induced ARF 
Variables Chi-square P Value Odds ratio 
Time lag >5 
hours 13.96 <0.0001 7.852 
WBCT 
>20Min 7.44 0.006377 10.8 
Hypotension 59.31 <0.0001 184.3 
Cellulitis 61.86 <0.0001 198.1 
Hematuria 53.22 <0.0001 81 
 
Clinical variable like lapse in time, WBCT >20 Mins, Cellulitis, 
hypotension & hematuria had statistical significance with development of 
ARF. In present study patients showed local envenomation (99%), hypotension 
(15%), hematuria (26%) and oliguria (20%). 
Srilatha et al64 found hematuria in 40% and oliguria 34% of patients 
with ARF. Mishra et al25 study had 25% of cases developing hypotension. 
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CONCLUSION 
 Snake bites are common in and around Vellore district. 
 Majority of the patients had signs of envenomation and a small number 
had snake bite without systemic envenomation. 
 Snake bite is an important and preventable cause of ARF.   
 Causes for ARF in snake bite are “multifactorial” in origin. Bleeding 
and hypotension are the important causative factors. 
 Type of snake bite is one of the important factors in the development of 
Acute Renal Failure. ARF is commonly associated with Viperidea 
species. 
 Delay in time in presenting to the hospital is one of the valid predictors 
of poor outcome in snake bite induced Acute Renal Failure. 
 Snake bite patients developing coagulopathy are more prone to develop 
ARF.  Snake bite patients presented with cellulitis as local manifestation 
are at increased risk to develop ARF. 
 In ARF complicated cases, Dialysis & supporting therapy appears to be 
the mainstay of treatment. 
 Anuria of more than 48 hours, severe hyperkalemia resistant to Medical 
therapy, pulmonary oedema, and progressive rise in Blood urea and 
serum creatinine are the main indications for dialysis in ARF. 
 Clinical outcome depends on optimum ASV dosage which is variable, 
depending on the type of snake, type of envenomation, organ system 
involved & supportive care offered. 
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PROFORMA 
 
 
PATIENT PARTICULARS 
 
Name  :    Hospital :  
Age  :    I.P. No. :  
Sex  : M/F   DOA  :  
Occupation :    DOD  :  
Address :   
 
 
EVIDENCE TO SNAKE BITE 
 
1. Snake seen                         :  Y/N 
2. Fang marks seen                :  Y/N 
3. Features of envenomation  :  Y/N 
 
DETAILS OF SNAKE 
 
• Snake: Seen /not seen /brought  
 
• Species of snake if known:  
 
 
DETAILS OF SNAKE BITE 
 
• Site of bite : Lower limb  :  Right /left  
 
Upper limb  :  Right /left 
 
     Other site:  
 
• Presence of fang marks   : Single/double  
 
• Time of bite    :  
 
• Time of hospital admission  :  
 
 
 
• Interval between bite and medical aid :  
 
• Premises      : Indoor/outdoor 
 
• Tourniquet      : applied or not 
 
CLINICAL EXAMINATION 
 
General examination : Conscious/drowsy/stupor/coma  
 
Vitals :   Pulse :                JVP:  Elevated/Not 
 
BP  : mm/Hg 
 
RR  : /min 
 
Temp  : F   
 
Pallor  : Y/N 
                                    
Icterus : Y/N 
 
Cyanosis : Y/N 
 
Clubbing : Y/N 
 
Lymphadenopathy :Y/N 
 
SIGNS OF ENVENOMATION  
 
LOCAL EXAMINATION:  
 
• Fang marks : Y/N  
 
• Pain   : Y/N 
 
• Swelling  : Y/N 
 
• Cellulites  : Y/N 
 
• Bleeding  : Y/N                       Others:        
 
 
 
 
HAEMATOXIC FEATURES 
 
 
• Bleeding from bite site   : Y/N  
 
• Bleeding from gums /gingival  : Y/N 
 
• Epistaxis     : Y/N  
  
• Ecchymosis / purpura /petechiae : Y/N 
 
 • Hematuria    : Y/N  
 
• Hematemesis    : Y/N  
 
• Hemoptysis    : Y/N 
 
 
NEUROTOXIC FEATURES 
 
• Ptosis     : Y/N 
 
• Ophthalmoplegia    : Y/N 
 
• Pharyngeal paralysis   : Y/N 
 
• Respiratory paralysis   : Y/N 
 
• Flaccid limb paralysis   : Y/N 
 
SYSTEMIC EXAMINATION 
 
CNS 
 
• State consciousness :   conscious/ unconscious         Pupil:       mm 
 
• Speech  :                 
 
• Cranial nerves :  
 
• Motor system :  
 
 
 
 
 CVS                                                               
 RS 
 KIDNEY    Normal 
Oliguria/Anuria 
 
 
INVESTIGATIONS 
 
• Complete haemogram  : Hb  TC         DC        ESR 
 
   Platelet                                      
 
• Bleeding time   :  
 
• Whole blood clotting time :  
 
• Urine examination  :  Albumin  
 
Sugar 
 
RBC  
 
 
 
• Blood urea:          Day 1:       Day 2:          Day 3:          Day 4:      Day 5: 
 
• Serum creatinine: Day 1:       Day 2:          Day 3:         Day 4:      Day 5: 
 
• Serum electrolytes:  
 
• If any other investigation:  
 
IMPRESSION:  
 
Venomous /non venomous 
 
Hemotoxic / Neurotoxic / Cardio toxic 
 
 
 
 
TREATMENT 
 
Anti-snake venom  :  
 
Total dose   : 
 
Hospital Stay  : 
 
Any adverse reactions : Y/N 
 
Fasciotomy   : Y/N                    site : 
 
Need of organ support : Ventilator :          No. of days 
 
Dialysis   : Y/N     No of Sittings 
 
 
OUTCOME 
 
Complete recovery / Disability (morbidity) / Death (mortality):  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
KEY TO MASTER CHART 
ES  - Snake seen 
FMS  - Fang Mark Seen 
SOB  - Site of bite 
RR  - Respiratory Rate 
H1  - Bleeding from bite site 
H2  - Mucosal bleed 
H3  - Epistaxis  
H4  - Petechiae / Ecchymoses 
H5  - Hematuria 
H6  - Hematemesis 
H7  - Hemoptysis 
N1  - Ptosis 
N2  - Opthalamoplegia 
N3  - Pharyngeal Paralysis 
N4  - Respiratory failure 
N5  - Motor Paralysis 
WBCT - Whole Blood Clotting Time 
U1  - Albumin 
U2  - Sugar 
U3  -  RBC 
UR 1- UR5 - Urea (Day1-Day 5) 
CR1 - CR5 - Creatinine (Day1-Day5) 
ASV  - Anti Snake Venom 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
